BDX Becton, Dickinson and Company
Stock Price & Overview

$171.02-4.32 (-2.46%)4:00 PM 05/14/25
NYSE | $USD | Post-Market: $170.98 -0.04 (-0.02%) 7:31 PM

BDX Stock Price

EPS
PE
Div Rate
Yield
Short Interest
Market Cap
Volume
Prev. Close

Quant Ranking

Latest Headlines

Ratings Summary

People Also Follow

Similar to BDX

ETFs Holding BDX

BDX Company Profile

Becton, Dickinson and Company logo
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, informatics and analytics and pharmacy automation systems, and medication inventory optimization and tracking systems; hemodynamic monitoring systems; and prefillable drug delivery systems. The BD Life Sciences segment offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The BD Interventional segment provides hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.
Employees
74,000
Founded
1897
Address
  • 1 Becton Drive
  • Franklin Lakes, NJ, 07417-1880
  • United States
Phone Number
201 847 6800
Website

BDX Earnings Per Share

Earnings Estimates

Earnings Revisions

Valuation

Growth

Profitability

Momentum

Capital Structure

BDX Dividend Growth History

BDX Ownership

BDX Peers

Risk

Technicals

BDX Transcripts

Investor Presentations

BDX SEC Filings

BDX Income Statement

BDX Balance Sheet

BDX Cash Flow Statement

BDX Long Term Solvency

Discover More

You may be interested in:

Becton, Dickinson and Company (BDX) Frequently Asked Questions